Market Tracker

12/13 5:15pm ET

Cascadian Therapeutics Inc (NASDAQ:CASC)

3.85
Delayed Data
As of 4:00pm ET
 +0.19 / +5.19%
Today’s Change
3.18
Today|||52-Week Range
6.13
-10.67%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close3.66
Today’s open3.70
Day’s range3.70 - 3.98
Volume559,921
Average volume (3 months)348,873
Market cap$185.0M
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-820.59%
Earnings growth (this year)+60.38%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...+0.10+3.12%
ARWRArrowhead Pharmaceut...-0.15-4.23%
CDXSCodexis Inc-0.05-0.65%
BCLIBrainstorm Cell Ther...+0.02+0.51%
Data as of 4:00pm ET, 12/13/2017

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$57.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts